4//SEC Filing
Delaney William E IV 4
Accession 0001209191-23-010529
CIK 0001426800other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:10 PM ET
Size
5.5 KB
Accession
0001209191-23-010529
Insider Transaction Report
Form 4
Delaney William E IV
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-02-16+10,000→ 88,919 total
Footnotes (2)
- [F1]Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.
- [F2]Includes 2,500 shares acquired under the Assembly Biosciences, Inc. Amended and Restated 2018 Employee Stock Purchase Plan on November 14, 2022.
Documents
Issuer
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Entity typeother
Related Parties
1- filerCIK 0001812734
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:10 PM ET
- Size
- 5.5 KB